AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
FOSFX
Price
$74.11
Change
+$0.31 (+0.42%)
Updated
Sep 5 closing price
Net Assets
7.21B
Interact to see
Advertisement

AEPCX vs FOSFX

Header iconAEPCX vs FOSFX Comparison
Open Charts AEPCX vs FOSFXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
Fidelity Overseas
Price$74.11
Change+$0.31 (+0.42%)
VolumeN/A
Net Assets7.21B
AEPCX vs FOSFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FOSFX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FOSFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FOSFX (7.21B). FOSFX pays higher dividends than AEPCX: FOSFX (1.17) vs AEPCX (0.16). AEPCX was incepted earlier than FOSFX: AEPCX (25 years) vs FOSFX (41 years). AEPCX (1.57) is less costly to investors than FOSFX (0.68). AEPCX (35.00) and FOSFX (35.00) have comparable annual turnover. FOSFX has a lower initial minimum investment than AEPCX: FOSFX (0) vs AEPCX (250). FOSFX annual gain was more profitable for investors over the last year : 12.44 vs. AEPCX (7.59). FOSFX return over 5 years is better than : 44.28 vs. AEPCX (7.78).
AEPCXFOSFXAEPCX / FOSFX
Total Expense Ratio1.570.68231%
Annual Report Gross Expense Ratio1.570.68231%
Fund Existence25 years41 years-
Gain YTD15.03818.38782%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B7.21B1,845%
Annual Yield % from dividends0.161.1714%
Returns for 1 year7.5912.4461%
Returns for 3 years32.6560.2254%
Returns for 5 years7.7844.2818%
Returns for 10 years34.3490.9138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.